Two UW researchers named AAAS Fellows

UW News

Two University of Washington researchers have been named AAAS Fellows, according to an April 18 announcement by the American Association for the Advancement of Science. They are among 502 newly elected fellows from around the world, who are recognized for their “scientifically and socially distinguished achievements” in science and engineering.

Bill & Melinda Gates Foundation: Maternal Immunization Safety Monitoring in Low- And Middle-Income Countries: A Roadmap for Program Development

By Eve Lackritz, Andy Stergachis, and Maria Stepanchak

The first 28 days of life (the neonatal period) are the most vulnerable for a child’s survival. Worldwide, almost half of all deaths in children under five years old occur during the first 28 days of life. Despite progress in recent decades, neonatal mortality remains the highest in low- and middle-income countries (LMICs), and 99% of all neonatal deaths occur in LMICs.

NewsBeat: Common Malaria Meds Pose No Undue Risk in Early Pregnancy

Global team finds that artemesinin therapies are as safe as quinine for women in first trimester

By Sarah C.B. Guthrie 

Artemisinin combination therapies (ACTs), medications widely used against malaria, are safe to administer to women in their first trimester of pregnancy, according to research published today. ACTs had previously been recommended at that stage of pregnancy only in life-saving circumstances.